Feature

Published: October 1, 2002
Find more content on:
General Recommendations to Carry out Effective Informed Consent for Clinical Trials in Japan


Originally Published MDDI October 2002

INTERNATIONAL AFFAIRS

  • Explain the purpose of the study clearly and simply.

  • Distinguish investigational treatment from standard care.
  • Avoid overstating the potential benefit of the investigational treatment.
  • Focus on physical and nonphysical risks associated with the investigational treatment as a whole.
  • Estimate broadly the likelihood of the risks associated with the investigational treatment.
  • Provide supplementary documents that are easy to read and culturally sensitive, and continue to provide these materials throughout the lifetime of the study.

Copyright ©2002 Medical Device & Diagnostic Industry


No votes yet